SCHEMBL9846132

SCHEMBL9846132

Cc1cc(N)c(=O)[nH]c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 4/20 0.53
PDE3A Q14432 4/20 0.53
PDE4A P27815 1/20 0.53
PDE4B Q07343 1/20 0.53
PDE4C Q08493 1/20 0.53
PDE4D Q08499 1/20 0.53
KDM4E B2RXH2 4/20 0.50
HPGD P15428 4/20 0.50
HSD17B10 Q99714 4/20 0.50
GAA P10253 3/20 0.50
AURKB Q96GD4 1/20 0.50
INCENP Q9NQS7 1/20 0.50
ALDH1A1 P00352 3/20 0.41
GLA P06280 2/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
PARP1 P09874 1/20 0.41
GRIN2D O15399 3/20 0.41
GRIN3B O60391 3/20 0.41
GRIN1 Q05586 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9431837 0.80 PDE3B (0.49) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL15478582 0.77 HSD17B10 (0.56) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9333284 0.76 PDE3B (0.49) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9681961 0.73 PDE3B (0.50) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL31639180 0.73 PDPK1 (0.41) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9680326 0.73 BRD4 (0.57) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL24550532 0.71 HSD17B10 (0.50) PDE3BPDE3AKDM4EHPGDHSD17B10
SCHEMBL27271864 0.71 HSD17B10 (0.50) PDE3BPDE3AKDM4EHPGDHSD17B10
SCHEMBL12946182 0.71 HSD17B10 (0.50) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9682098 0.71 PDE3B (0.45) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0462808-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed
EP-0462800-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed